Search

Search Constraints

You searched for: Author/Creator Grebely, Jason

Search Results

2. Chronic hepatitis C burden and care cascade in Australia in the era of interferon‐based treatment. Issue 1 (January 2017)

3. Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection. (5th July 2016)

4. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada. (28th May 2019)

5. Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies. (1st January 2019)

6. Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study. Issue 8 (2nd May 2019)

7. Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study. Issue 9 (11th June 2019)

8. Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study. Issue 1 (14th November 2018)

9. Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study. (July 2017)

10. Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study. Issue 12 (18th September 2019)